R. Bataille et al., EFFECTS OF AN ANTI-INTERLEUKIN-6 (IL-6) MURINE MONOCLONAL-ANTIBODY INA PATIENT WITH ACUTE MONOBLASTIC LEUKEMIA, Medical oncology and tumor pharmacotherapy, 10(4), 1993, pp. 185-188
Because IL-6 has been involved in the pathogenesis of acute monoblasti
c leukemia, we investigated the in vitro and-proliferative effect and
the in vivo and-tumoral effect of an and-IL-6 murine monoclonal antibo
dy (mAb) in a patient with M5B type acute leukemia. In the current stu
dy, we clearly show the IL-6 dependence of monoblastic cell viability
and proliferation in vitro in short-term cultures of malignant cells a
nd the clinical activity of the anti-IL-6 murine mAb. The complete neu
tralization of IL-6 in vivo was associated with a transient but comple
te disappearance of malignant monoblastic cells in the peripheral bloo
d, with improvement or even normalization of several other biological
parameters of disease activity. No immunization against the anti-IL-6
murine mAb was observed.